Aradigm

YTD

ALL

Why Robinhood?

You can watch Aradigm and buy or sell other stocks, ETFs, and their options commission-free!

About ARDMQ

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.

CEO

John M. Siebert, PhD

CEOJohn M. Siebert, PhD

Employees

—

Employees—

Headquarters

Hayward, California

HeadquartersHayward, California

Founded

1991

Founded1991

Employees

—

Employees—

ARDMQ Key Statistics

Market cap

702.90K

Market cap702.90K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

19.67K

Average volume19.67K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.20

52 Week high$0.20

52 Week low

$0.016

52 Week low$0.016